Climb Bio, Inc. CLYM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -32.1%+14.1pp | -46.3%-16.5pp | -29.7%+0.9pp | -30.6%— | |
| Return on invested capital | -54.2%+63.0pp | -117.2%-37.0pp | -80.2%-36.5pp | -43.7%— | |
| Liquidity | |||||
| Current ratio | 15.2×-16.3× | 31.4×-7.5× | 38.9×+16.9× | 22×-2.5× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $2.37-46.2% | $4.40+10.3% | $3.99-18.5% | $4.89-64.1% | |
| Valuation | |||||
| Market capitalization | $724.95M+787% | $121M— | —— | —— | |
| Price / book | 4.9×+4.5× | 0.6×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Climb Bio, Inc.'s ratios come from?
- Every ratio is computed from Climb Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.